PE000060

Name	R.VLSN[H5N4S2]NSDANLELINTWVAK.N
Sequence	VLSNNSDANLELINTWVAK
Glycans(s)	H5N4S2 (N4)
Mod(s)
Molecular Weight	4322.868
Norm. RT	116.380
Protein	SERPING1 (P05155)

Samples

Human Serum

DDA Transition Groups

	Exp. R.T.	Peak R.T.	Norm. R.T.	Prec. m/z	Prec. z	Inst.	Sample	Transitions
TG005072	60.458	60.415	119.279	1,077.222	4	Orbitrap	Human Serum	6
TG003306	58.724	58.496	113.729	1,077.222	4	Orbitrap	Human Serum	4
TG005491	79.191	79.153	120.219	1,077.222	4	Orbitrap	Human Serum	6
TG002516	58.107	58.201	115.684	1,077.222	4	Orbitrap	Human Serum	6
TG000994	57.874	57.928	116.380	1,435.960	3	Orbitrap	Human Serum	7
TG000687	58.135	57.893	115.698	1,077.222	4	Orbitrap	Human Serum	7
TG002701	58.124	58.135	116.842	1,077.222	4	Orbitrap	Human Serum	6

DIA Transition Groups

	Exp. R.T.	Peak R.T.	Norm. R.T.	Prec. m/z	Prec. z	Inst.	Sample	Intensity
TG003955	58.731	58.731	115.074	1,435.960	3	Orbitrap	Human Serum	2,757,610
TG008019	41.556	41.556	104.696	1,077.222	4	TripleTOF	Human Serum	287,535
TG009235	41.640	41.640	106.964	1,077.222	4	TripleTOF	Human Serum	217,843
TG008310	41.632	41.632	108.886	1,077.222	4	TripleTOF	Human Serum	207,002
TG008911	41.059	41.059	107.076	1,077.222	4	TripleTOF	Human Serum	174,884
TG008618	41.574	41.574	106.309	1,077.222	4	TripleTOF	Human Serum	168,637
TG008064	41.562	41.562	104.719	1,435.960	3	TripleTOF	Human Serum	146,409
TG008360	41.635	41.635	108.902	1,435.960	3	TripleTOF	Human Serum	120,809
TG009957	41.559	41.559	107.060	1,077.222	4	TripleTOF	Human Serum	110,655
TG009530	41.508	41.508	108.202	1,077.222	4	TripleTOF	Human Serum	99,829.8
TG008967	41.065	41.065	107.101	1,435.960	3	TripleTOF	Human Serum	78,554.9
TG010403	41.316	41.316	105.481	1,077.222	4	TripleTOF	Human Serum	68,985